output/noOutl_v10/byLines/noOutl_v10_byLines_1_Data-tags.csv Version 1
_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP1012-finalG/_A_04_MapManBINenrich-GSEA/
SEEK ID: https://fairdomhub.org/data_files/5437?version=1
Filename:
output/noOutl_v10/byLines/noOutl_v10_byLines_1_Data-tags.csv
Format: Plain text document
Size: 18.3 KB
NAME SIZE high1_vs_wt-up high2_vs_wt-up low1_vs_wt-up low2_vs_wt-up NAME SIZE high1_vs_wt-down high2_vs_wt-down low1_vs_wt-down low2_vs_wt-down 1.1.1.1 PS.LIGHTREACTION.PHOTOSYSTEM II.LHC-II 34 -91% -97% +74% -62% 1.1.1.2 PS.LIGHTREACTION.PHOTOSYSTEM II.PSII POLYPEPTIDE SUBUNITS 59 -93% -93% +100% -68% 1.1.2.1 PS.LIGHTREACTION.PHOTOSYSTEM I.LHC-I 28 -96% -96% +57% -100% 1.1.2.2 PS.LIGHTREACTION.PHOTOSYSTEM I.PSI POLYPEPTIDE SUBUNITS 35 -97% -97% +66% -97% 1.3.6 PS.CALVIN CYCLE.ALDOLASE 17 -29% -53% +53% -47% 1.3.13 PS.CALVIN CYCLE.RUBISCO INTERACTING 26 -85% -85% -12% -69% 2.1.2.2 MAJOR CHO METABOLISM.SYNTHESIS.STARCH.STARCH SYNTHASE 18 -50% +6% +6% +28% 2.2.2.1.2 MAJOR CHO METABOLISM.DEGRADATION.STARCH.STARCH CLEAVAGE.BETA AMYLASE 17 +35% +35% +41% +53% 3.2.3 MINOR CHO METABOLISM.TREHALOSE.POTENTIAL TPS/TPP 17 +24% +24% +18% +71% 3.5 MINOR CHO METABOLISM.OTHERS 56 +20% +18% -34% -14% 3.6 MINOR CHO METABOLISM.CALLOSE 18 +44% +28% +17% +22% 4.1.16 GLYCOLYSIS.CYTOSOLIC BRANCH.PHOSPHO-ENOL-PYRUVATE CARBOXYLASE KINASE (PPCK) 15 +27% -53% +27% +27% 8.1.1.1 TCA / ORG TRANSFORMATION.TCA.PYRUVATE DH.E1 15 +27% +20% +27% -80% 9.1.2 MITOCHONDRIAL ELECTRON TRANSPORT / ATP SYNTHESIS.NADH-DH.LOCALISATION NOT CLEAR 40 +80% +52% -10% -63% 9.6 MITOCHONDRIAL ELECTRON TRANSPORT / ATP SYNTHESIS.CYTOCHROME C 15 +33% -27% -13% -40% 9.7 MITOCHONDRIAL ELECTRON TRANSPORT / ATP SYNTHESIS.CYTOCHROME C OXIDASE 18 +50% +11% -17% -22% 9.9 MITOCHONDRIAL ELECTRON TRANSPORT / ATP SYNTHESIS.F1-ATPASE 32 +56% -3% +66% -72% 10.1.6 CELL WALL.PRECURSOR SYNTHESIS.GAE 19 -53% -53% -42% -42% 10.2 CELL WALL.CELLULOSE SYNTHESIS 24 -67% +42% +54% +4% 10.2.1 CELL WALL.CELLULOSE SYNTHESIS.CELLULOSE SYNTHASE 35 -60% +6% +14% -26% 10.5.1.1 CELL WALL.CELL WALL PROTEINS.AGPS.AGP 21 -81% -33% -24% -76% 10.6.1 CELL WALL.DEGRADATION.CELLULASES AND BETA -1,4-GLUCANASES 23 -48% -61% -13% -39% 10.6.2 CELL WALL.DEGRADATION.MANNAN-XYLOSE-ARABINOSE-FUCOSE 29 +48% +24% -24% -28% 10.6.3 CELL WALL.DEGRADATION.PECTATE LYASES AND POLYGALACTURONASES 50 -44% -32% +30% -34% 10.7 CELL WALL.MODIFICATION 55 +18% +33% +27% -36% 10.8.1 CELL WALL.PECTIN*ESTERASES.PME 32 -31% -22% -28% -25% 11.1.8 LIPID METABOLISM.FA SYNTHESIS AND FA ELONGATION.ACYL COA LIGASE 23 +52% +48% +39% +43% 11.3 LIPID METABOLISM.PHOSPHOLIPID SYNTHESIS 18 -39% -44% -11% +28% 11.6 LIPID METABOLISM.LIPID TRANSFER PROTEINS ETC 24 +42% +21% +38% +38% 11.8 LIPID METABOLISM.EXOTICS(STEROIDS, SQUALENE ETC) 17 +24% +29% +12% +35% 11.8.1 LIPID METABOLISM.EXOTICS (STEROIDS, SQUALENE ETC).SPHINGOLIPIDS 47 -23% -28% -26% -17% 11.9.2 LIPID METABOLISM.LIPID DEGRADATION.LIPASES 25 +48% +32% -32% +48% 11.9.2.1 LIPID METABOLISM.LIPID DEGRADATION.LIPASES.TRIACYLGLYCEROL LIPASE 31 +32% +32% -26% +45% 11.9.3.1 LIPID METABOLISM.LIPID DEGRADATION.LYSOPHOSPHOLIPASES.PHOSPHOLIPASE D 15 -27% -27% -40% -40% 11.9.3.2 LIPID METABOLISM.LIPID DEGRADATION.LYSOPHOSPHOLIPASES.CARBOXYLESTERASE 22 +50% +50% -27% -27% 11.9.4.3 LIPID METABOLISM.LIPID DEGRADATION.BETA-OXIDATION.ENOYL COA HYDRATASE 15 +47% +47% +47% +53% 11.9.4.5 LIPID METABOLISM.LIPID DEGRADATION.BETA-OXIDATION.ACYL-COA THIOESTERASE 17 +47% +65% -41% +71% 13.1.3.4 AMINO ACID METABOLISM.SYNTHESIS.ASPARTATE FAMILY.METHIONINE 27 -70% -7% -30% -74% 13.2.6.3 AMINO ACID METABOLISM.DEGRADATION.AROMATIC AA.TRYPTOPHAN 19 +84% +74% +42% +53% 15.2 METAL HANDLING.BINDING, CHELATION AND STORAGE 49 +37% -20% -31% +20% 16.2 SECONDARY METABOLISM.PHENYLPROPANOIDS 25 +48% +44% -20% +32% 16.7 SECONDARY METABOLISM.WAX 20 -35% -40% +20% +35% 16.8.3 SECONDARY METABOLISM.FLAVONOIDS.DIHYDROFLAVONOLS 23 +35% +35% +13% +43% 16.8.4 SECONDARY METABOLISM.FLAVONOIDS.FLAVONOLS 21 +57% +43% +19% +43% 17.1.2 HORMONE METABOLISM.ABSCISIC ACID.SIGNAL TRANSDUCTION 25 +76% +76% +40% +56% 17.1.3 HORMONE METABOLISM.ABSCISIC ACID.INDUCED-REGULATED-RESPONSIVE-ACTIVATED 21 +67% +67% +33% +38% 17.2.2 HORMONE METABOLISM.AUXIN.SIGNAL TRANSDUCTION 45 -24% +100% +22% +40% 17.2.3 HORMONE METABOLISM.AUXIN.INDUCED-REGULATED-RESPONSIVE-ACTIVATED 89 +18% -11% +22% +33% 17.3.2.99 HORMONE METABOLISM.BRASSINOSTEROID.SIGNAL TRANSDUCTION.OTHER 15 -20% +47% +20% +27% 17.4.1 HORMONE METABOLISM.CYTOKININ.SYNTHESIS-DEGRADATION 15 -13% -13% +73% +40% 17.5.1 HORMONE METABOLISM.ETHYLENE.SYNTHESIS-DEGRADATION 25 +36% +12% +24% +48% 17.5.2 HORMONE METABOLISM.ETHYLENE.SIGNAL TRANSDUCTION 43 +35% +14% -42% +26% 17.5.3 HORMONE METABOLISM.ETHYLENE.INDUCED-REGULATED-RESPONSIVE-ACTIVATED 20 +55% +55% +35% +50% 17.8.1 HORMONE METABOLISM.SALICYLIC ACID.SYNTHESIS-DEGRADATION 20 +10% +40% -40% +60% 18 CO-FACTOR AND VITAMINE METABOLISM 27 -26% -41% -15% +26% 18.7 CO-FACTOR AND VITAMINE METABOLISM.IRON-SULPHUR CLUSTERS 15 +80% +87% -13% +20% 20.1 STRESS.BIOTIC 184 +34% +37% -22% +28% 20.1.7 STRESS.BIOTIC.PR-PROTEINS 95 +21% +32% -40% +11% 20.2 STRESS.ABIOTIC 41 +20% +27% +17% +20% 20.2.1 STRESS.ABIOTIC.HEAT 276 +19% +28% +11% +17% 20.2.2 STRESS.ABIOTIC.COLD 26 +42% +62% -19% +38% 20.2.3 STRESS.ABIOTIC.DROUGHT/SALT 97 -35% +26% -30% +14% 20.2.4 STRESS.ABIOTIC.TOUCH/WOUNDING 16 +56% +56% -31% +44% 20.2.5 STRESS.ABIOTIC.LIGHT 16 -31% -19% +56% +50% 20.2.99 STRESS.ABIOTIC.UNSPECIFIED 52 +42% +31% -27% +27% 21.1 REDOX.THIOREDOXIN 83 +22% -49% -6% +13% 21.1.1 REDOX.THIOREDOXIN.PDIL 20 +35% +50% -30% -60% 21.2 REDOX.ASCORBATE AND GLUTATHIONE 50 +54% +38% +26% +20% 21.2.1 REDOX.ASCORBATE AND GLUTATHIONE.ASCORBATE 27 -11% -19% -37% -41% 21.2.2 REDOX.ASCORBATE AND GLUTATHIONE.GLUTATHIONE 23 +30% -39% +22% +22% 21.4 REDOX.GLUTAREDOXINS 29 -24% -28% +31% -17% 21.6 REDOX.DISMUTASES AND CATALASES 19 +11% -53% +11% +26% 23.2 NUCLEOTIDE METABOLISM.DEGRADATION 37 +19% +32% -38% +22% 23.3.3 NUCLEOTIDE METABOLISM.SALVAGE.NUDIX HYDROLASES 24 +42% +42% +25% +54% 23.4.99 NUCLEOTIDE METABOLISM.PHOSPHOTRANSFER AND PYROPHOSPHATASES.MISC 15 +40% +27% +7% -47% 24 BIODEGRADATION OF XENOBIOTICS 18 +50% +56% -22% -11% 25.1 C1-METABOLISM.GLYCINE HYDROXYMETHYLTRANSFERASE 15 -60% -13% -27% -53% 26.1 MISC.MISC2 44 +39% +30% +30% +27% 26.2 MISC.UDP GLUCOSYL AND GLUCORONYL TRANSFERASES 193 +16% +23% -31% +28% 26.3 MISC.GLUCO-, GALACTO- AND MANNOSIDASES 46 +22% +26% +20% +15% 26.3.2 MISC.GLUCO-, GALACTO- AND MANNOSIDASES.BETA-GALACTOSIDASE 21 -38% -48% +33% +48% 26.4 MISC.BETA 1,3 GLUCAN HYDROLASES 20 +30% +40% -35% -55% 26.4.1 MISC.BETA 1,3 GLUCAN HYDROLASES.GLUCAN ENDO-1,3-BETA-GLUCOSIDASE 40 +15% +25% -30% -43% 26.5 MISC.ACYL TRANSFERASES 18 -22% +22% +50% +28% 26.6 MISC.O-METHYL TRANSFERASES 22 -64% -14% +27% -32% 26.7 MISC.OXIDASES - COPPER, FLAVONE ETC 104 +36% +39% -27% +24% 26.8 MISC.NITRILASES, *NITRILE LYASES, BERBERINE BRIDGE ENZYMES, RETICULINE OXIDASES, TROPONINE REDUCTASES 43 +35% +28% +26% +33% 26.9 MISC.GLUTATHIONE S TRANSFERASES 36 +53% +42% +22% +58% 26.10 MISC.CYTOCHROME P450 102 +43% +48% +31% +53% 26.12 MISC.PEROXIDASES 29 +52% +45% +38% +34% 26.13 MISC.ACID AND OTHER PHOSPHATASES 81 +49% +49% +46% +32% 26.16 MISC.MYROSINASES-LECTIN-JACALIN 18 -22% -28% -44% +33% 26.19 MISC.PLASTOCYANIN-LIKE 22 +41% +41% -32% -36% 26.21 MISC.PROTEASE INHIBITOR/SEED STORAGE/LIPID TRANSFER PROTEIN (LTP) FAMILY PROTEIN 44 -45% -48% -18% +23% 26.22 MISC.SHORT CHAIN DEHYDROGENASE/REDUCTASE (SDR) 34 +44% +32% -18% +38% 26.24 MISC.GCN5-RELATED N-ACETYLTRANSFERASE 31 -16% -26% -45% +32% 26.28 MISC.GDSL-MOTIF LIPASE 51 -37% -33% +18% -20% 27.1 RNA.PROCESSING 185 -45% -38% +24% -34% 27.1.1 RNA.PROCESSING.SPLICING 119 -39% +97% +22% +12% 27.1.2 RNA.PROCESSING.RNA HELICASE 70 -67% -47% +21% -57% 27.1.19 RNA.PROCESSING.RIBONUCLEASES 69 +28% -30% +14% +13% 27.2 RNA.TRANSCRIPTION 136 -19% -27% +28% -32% 27.3 RNA.REGULATION OF TRANSCRIPTION 26 -31% -31% -42% -46% 27.3.3 RNA.REGULATION OF TRANSCRIPTION.AP2/EREBP, APETALA2/ETHYLENE-RESPONSIVE ELEMENT BINDING PROTEIN FAMILY 55 +40% +51% +16% +33% 27.3.4 RNA.REGULATION OF TRANSCRIPTION.ARF, AUXIN RESPONSE FACTOR FAMILY 37 -51% -49% -46% +46% 27.3.5 RNA.REGULATION OF TRANSCRIPTION.ARR 17 +18% -29% -18% -53% 27.3.6 RNA.REGULATION OF TRANSCRIPTION.BHLH,BASIC HELIX-LOOP-HELIX FAMILY 120 -14% +34% -21% +43% 27.3.7 RNA.REGULATION OF TRANSCRIPTION.C2C2(ZN) CO-LIKE, CONSTANS-LIKE ZINC FINGER FAMILY 31 +10% +10% +39% +45% 27.3.8 RNA.REGULATION OF TRANSCRIPTION.C2C2(ZN) DOF ZINC FINGER FAMILY 26 +50% +46% -27% +42% 27.3.9 RNA.REGULATION OF TRANSCRIPTION.C2C2(ZN) GATA TRANSCRIPTION FACTOR FAMILY 37 +30% +30% +32% +43% 27.3.11 RNA.REGULATION OF TRANSCRIPTION.C2H2 ZINC FINGER FAMILY 80 -24% -14% +9% -11% 27.3.12 RNA.REGULATION OF TRANSCRIPTION.C3H ZINC FINGER FAMILY 34 +26% +32% +12% +26% 27.3.20 RNA.REGULATION OF TRANSCRIPTION.G2-LIKE TRANSCRIPTION FACTOR FAMILY, GARP 42 +26% +31% -38% +24% 27.3.22 RNA.REGULATION OF TRANSCRIPTION.HB,HOMEOBOX TRANSCRIPTION FACTOR FAMILY 88 +34% +36% -19% +41% 27.3.23 RNA.REGULATION OF TRANSCRIPTION.HSF,HEAT-SHOCK TRANSCRIPTION FACTOR FAMILY 26 +12% +12% +12% +23% 27.3.24 RNA.REGULATION OF TRANSCRIPTION.MADS BOX TRANSCRIPTION FACTOR FAMILY 18 +33% +39% +28% +39% 27.3.25 RNA.REGULATION OF TRANSCRIPTION.MYB DOMAIN TRANSCRIPTION FACTOR FAMILY 86 -9% +28% -33% +26% 27.3.26 RNA.REGULATION OF TRANSCRIPTION.MYB-RELATED TRANSCRIPTION FACTOR FAMILY 62 -15% -15% -19% +32% 27.3.29 RNA.REGULATION OF TRANSCRIPTION.TCP TRANSCRIPTION FACTOR FAMILY 28 -46% -29% +11% -25% 27.3.30 RNA.REGULATION OF TRANSCRIPTION.TRIHELIX, TRIPLE-HELIX TRANSCRIPTION FACTOR FAMILY 42 +36% +2% -26% +38% 27.3.32 RNA.REGULATION OF TRANSCRIPTION.WRKY DOMAIN TRANSCRIPTION FACTOR FAMILY 56 +61% +64% -29% +45% 27.3.34 RNA.REGULATION OF TRANSCRIPTION.ORPHAN FAMILY 19 -68% -58% +32% +47% 27.3.35 RNA.REGULATION OF TRANSCRIPTION.BZIP TRANSCRIPTION FACTOR FAMILY 100 +39% +47% -20% +22% 27.3.40 RNA.REGULATION OF TRANSCRIPTION.AUX/IAA FAMILY 28 +25% +25% +64% +54% 27.3.44 RNA.REGULATION OF TRANSCRIPTION.CHROMATIN REMODELING FACTORS 70 -29% -30% +26% +31% 27.3.50 RNA.REGULATION OF TRANSCRIPTION.GENERAL TRANSCRIPTION 33 -9% -48% +39% -36% 27.3.52 RNA.REGULATION OF TRANSCRIPTION.GLOBAL TRANSCRIPTION FACTOR GROUP 34 -9% +9% +32% +12% 27.3.54 RNA.REGULATION OF TRANSCRIPTION.HISTONE ACETYLTRANSFERASES 22 -41% +32% +36% +18% 27.3.55 RNA.REGULATION OF TRANSCRIPTION.HDA 26 +27% +23% +35% -35% 27.3.57 RNA.REGULATION OF TRANSCRIPTION.JUMONJI FAMILY 17 -29% +29% +18% +29% 27.3.59 RNA.REGULATION OF TRANSCRIPTION.METHYL BINDING DOMAIN PROTEINS 20 +10% -5% +10% +25% 27.3.63 RNA.REGULATION OF TRANSCRIPTION.PHD FINGER TRANSCRIPTION FACTOR 30 -50% -30% +30% -100% 27.3.67 RNA.REGULATION OF TRANSCRIPTION.PUTATIVE TRANSCRIPTION REGULATOR 271 +12% +7% +22% +15% 27.3.68 RNA.REGULATION OF TRANSCRIPTION.PWWP DOMAIN PROTEIN 19 -63% +32% +32% +37% 27.3.69 RNA.REGULATION OF TRANSCRIPTION.SET-DOMAIN TRANSCRIPTIONAL REGULATOR FAMILY 48 -52% -40% +42% -19% 27.3.71 RNA.REGULATION OF TRANSCRIPTION.SNF7 20 +80% +80% +20% +10% 27.3.73 RNA.REGULATION OF TRANSCRIPTION.ZN-FINGER(CCHC) 20 -40% -100% +50% -45% 27.3.99 RNA.REGULATION OF TRANSCRIPTION.UNCLASSIFIED 482 -21% +23% -19% +16% 27.4 RNA.RNA BINDING 357 -25% -31% +21% -29% 28.1 DNA.SYNTHESIS/CHROMATIN STRUCTURE 326 -50% -38% +33% -27% 28.1.3.2.1 DNA.SYNTHESIS/CHROMATIN STRUCTURE.HISTONE.CORE.H2A 37 -54% -70% +76% -84% 28.1.3.2.2 DNA.SYNTHESIS/CHROMATIN STRUCTURE.HISTONE.CORE.H2B 16 -69% -88% +100% -81% 28.1.3.2.3 DNA.SYNTHESIS/CHROMATIN STRUCTURE.HISTONE.CORE.H3 17 -53% -71% +82% -71% 28.1.3.2.4 DNA.SYNTHESIS/CHROMATIN STRUCTURE.HISTONE.CORE.H4 22 -64% -86% +91% -86% 28.2 DNA.REPAIR 100 -39% -35% +33% -10% 28.99 DNA.UNSPECIFIED 207 -27% +25% +28% +28% 29.1 PROTEIN.AA ACTIVATION 15 -33% -47% +47% -40% 29.1.30 PROTEIN.AA ACTIVATION.PSEUDOURIDYLATE SYNTHASE 21 -57% -24% -33% -57% 29.2.2 PROTEIN.SYNTHESIS.RIBOSOME BIOGENESIS 18 +6% +6% -50% +11% 29.2.2.1 PROTEIN.SYNTHESIS.RIBOSOME BIOGENESIS.EXPORT FROM NUCLEUS 18 +22% +22% +39% +17% 29.2.2.3.1 PROTEIN.SYNTHESIS.RIBOSOME BIOGENESIS.PRE-RRNA PROCESSING AND MODIFICATIONS.SNORNPS 28 -64% -79% +68% -57% 29.2.2.3.3 PROTEIN.SYNTHESIS.RIBOSOME BIOGENESIS.PRE-RRNA PROCESSING AND MODIFICATIONS.METHYLOTRANSFERASES 23 -74% -57% -22% -61% 29.2.2.3.5 PROTEIN.SYNTHESIS.RIBOSOME BIOGENESIS.PRE-RRNA PROCESSING AND MODIFICATIONS.DEXD-BOX HELICASES 26 -42% -4% +50% -46% 29.2.3 PROTEIN.SYNTHESIS.INITIATION 155 -5% -41% +38% -35% 29.2.4 PROTEIN.SYNTHESIS.ELONGATION 73 -25% -30% +15% -78% 29.2.5 PROTEIN.SYNTHESIS.RELEASE 19 -37% -68% -21% -32% 29.3.1 PROTEIN.TARGETING.NUCLEUS 81 -20% -10% +37% -40% 29.3.2 PROTEIN.TARGETING.MITOCHONDRIA 43 +100% -40% +33% -51% 29.3.3 PROTEIN.TARGETING.CHLOROPLAST 64 -66% -61% +3% -50% 29.3.4.1 PROTEIN.TARGETING.SECRETORY PATHWAY.ER 34 +68% +68% -18% +12% 29.3.4.2 PROTEIN.TARGETING.SECRETORY PATHWAY.GOLGI 24 +33% +67% +58% +33% 29.3.4.3 PROTEIN.TARGETING.SECRETORY PATHWAY.VACUOLE 53 +53% +62% -17% +57% 29.3.4.99 PROTEIN.TARGETING.SECRETORY PATHWAY.UNSPECIFIED 145 +53% +56% +23% +15% 29.3.5 PROTEIN.TARGETING.PEROXISOMES 23 +4% +100% -52% +48% 29.4.1 PROTEIN.POSTRANSLATIONAL MODIFICATION.KINASE 60 +33% +38% +30% +38% 29.4.1.57 PROTEIN.POSTRANSLATIONAL MODIFICATION.KINASE.RECEPTOR LIKE CYTOPLASMATIC KINASE VII 58 +29% +38% -22% +21% 29.5 PROTEIN.DEGRADATION 225 -17% -15% +18% +27% 29.5.1 PROTEIN.DEGRADATION.SUBTILASES 40 -30% +18% -18% +20% 29.5.2 PROTEIN.DEGRADATION.AUTOPHAGY 26 +69% +65% -23% +81% 29.5.3 PROTEIN.DEGRADATION.CYSTEINE PROTEASE 68 +43% +40% +10% +41% 29.5.4 PROTEIN.DEGRADATION.ASPARTATE PROTEASE 55 -18% -24% +36% +29% 29.5.5 PROTEIN.DEGRADATION.SERINE PROTEASE 108 +23% +25% +19% +25% 29.5.7 PROTEIN.DEGRADATION.METALLOPROTEASE 59 -54% -49% +14% -27% 29.5.9 PROTEIN.DEGRADATION.AAA TYPE 48 +17% +29% +21% +4% 29.5.11 PROTEIN.DEGRADATION.UBIQUITIN 126 +41% +26% +13% -13% 29.5.11.1 PROTEIN.DEGRADATION.UBIQUITIN.UBIQUITIN 46 +41% +35% -26% +50% 29.5.11.3 PROTEIN.DEGRADATION.UBIQUITIN.E2 73 +55% +67% +12% +51% 29.5.11.4.1 PROTEIN.DEGRADATION.UBIQUITIN.E3.HECT 22 -9% +64% -23% +32% 29.5.11.4.3.1 PROTEIN.DEGRADATION.UBIQUITIN.E3.SCF.SKP 23 +61% +57% -30% +35% 29.5.11.4.3.2 PROTEIN.DEGRADATION.UBIQUITIN.E3.SCF.FBOX 252 +36% +21% -30% +34% 29.5.11.4.5.2 PROTEIN.DEGRADATION.UBIQUITIN.E3.BTB/POZ CULLIN3.BTB/POZ 20 +25% +5% -25% +50% 29.5.11.5 PROTEIN.DEGRADATION.UBIQUITIN.UBIQUITIN PROTEASE 51 +33% +37% +20% +33% 29.5.11.20 PROTEIN.DEGRADATION.UBIQUITIN.PROTEASOM 132 +67% +68% +33% +13% 29.6 PROTEIN.FOLDING 135 -36% -38% +9% -53% 29.7 PROTEIN.GLYCOSYLATION 56 +7% +48% -25% -20% 29.8 PROTEIN.ASSEMBLY AND COFACTOR LIGATION 40 -43% -58% +13% +30% 30.1 SIGNALLING.IN SUGAR AND NUTRIENT PHYSIOLOGY 53 +30% +26% -13% -17% 30.2.2 SIGNALLING.RECEPTOR KINASES.LEUCINE RICH REPEAT II 22 -14% -36% +32% +50% 30.2.3 SIGNALLING.RECEPTOR KINASES.LEUCINE RICH REPEAT III 55 -69% -45% +51% -45% 30.2.6 SIGNALLING.RECEPTOR KINASES.LEUCINE RICH REPEAT VI 21 -33% -38% -19% -24% 30.2.8.2 SIGNALLING.RECEPTOR KINASES.LEUCINE RICH REPEAT VIII.VIII-2 17 +29% +35% -35% -12% 30.2.9 SIGNALLING.RECEPTOR KINASES.LEUCINE RICH REPEAT IX 16 -63% -56% +50% -25% 30.2.10 SIGNALLING.RECEPTOR KINASES.LEUCINE RICH REPEAT X 21 +52% +52% -29% -29% 30.2.11 SIGNALLING.RECEPTOR KINASES.LEUCINE RICH REPEAT XI 52 -38% +27% -33% -25% 30.2.16 SIGNALLING.RECEPTOR KINASES.CATHARANTHUS ROSEUS-LIKE RLK1 28 -43% -32% -36% -54% 30.2.17 SIGNALLING.RECEPTOR KINASES.DUF 26 56 +36% +46% +30% +38% 30.2.19 SIGNALLING.RECEPTOR KINASES.LEGUME-LECTIN 18 +67% +61% +17% +50% 30.2.20 SIGNALLING.RECEPTOR KINASES.WHEAT LRK10 LIKE 22 +41% +50% -32% +36% 30.2.22 SIGNALLING.RECEPTOR KINASES.PROLINE EXTENSIN LIKE 20 -40% +30% -15% -55% 30.2.24 SIGNALLING.RECEPTOR KINASES.S-LOCUS GLYCOPROTEIN LIKE 29 +24% +34% -41% +41% 30.2.99 SIGNALLING.RECEPTOR KINASES.MISC 29 +31% +38% +28% +21% 30.3 SIGNALLING.CALCIUM 317 +26% +33% -26% -22% 30.4 SIGNALLING.PHOSPHINOSITIDES 32 +53% +50% +28% +44% 30.4.1 SIGNALLING.PHOSPHINOSITIDES.PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE 31 -52% +39% +26% +35% 30.5 SIGNALLING.G-PROTEINS 327 -26% -20% +17% -32% 30.6 SIGNALLING.MAP KINASES 86 +37% +43% +23% +31% 30.7 SIGNALLING.14-3-3 PROTEINS 33 -100% +100% +45% -42% 30.11 SIGNALLING.LIGHT 159 +24% +23% +40% +31% 30.11.1 SIGNALLING.LIGHT.COP9 SIGNALOSOME 19 +63% +68% +26% -26% 31.1 CELL.ORGANISATION 345 -19% -15% -28% -21% 31.1.1.1.1 CELL.ORGANISATION.CYTOSKELETON.ACTIN.ACTIN 21 +19% +19% -24% -48% 31.1.1.2 CELL.ORGANISATION.CYTOSKELETON.MIKROTUBULI 65 -43% -46% +35% -20% 31.2 CELL.DIVISION 147 -22% -8% +26% -19% 31.3 CELL.CYCLE 86 -37% -21% +35% -30% 31.3.1 CELL.CYCLE.PEPTIDYLPROLYL ISOMERASE 55 +51% -20% -24% -22% 31.4 CELL.VESICLE TRANSPORT 278 +37% +50% +23% +26% 33.3 DEVELOPMENT.SQUAMOSA PROMOTER BINDING LIKE (SPL) 26 -31% +12% -38% +42% 34.1 TRANSPORT.P- AND V-ATPASES 53 -30% +42% +19% -13% 34.1.1 TRANSPORT.P- AND V-ATPASES.H+-TRANSPORTING TWO-SECTOR ATPASE 25 +52% +44% -100% -48% 34.2 TRANSPORT.SUGARS 73 +22% +29% +21% +34% 34.3 TRANSPORT.AMINO ACIDS 73 +34% +42% +18% +34% 34.4 TRANSPORT.NITRATE 28 +61% +43% +57% +57% 34.7 TRANSPORT.PHOSPHATE 19 +37% +37% -42% -26% 34.8 TRANSPORT.METABOLITE TRANSPORTERS AT THE ENVELOPE MEMBRANE 60 -30% +7% +33% -45% 34.9 TRANSPORT.METABOLITE TRANSPORTERS AT THE MITOCHONDRIAL MEMBRANE 96 +26% +23% -22% -27% 34.10 TRANSPORT.NUCLEOTIDES 20 -25% +20% -35% +45% 34.12 TRANSPORT.METAL 100 +33% +24% -14% +31% 34.13 TRANSPORT.PEPTIDES AND OLIGOPEPTIDES 52 +46% +46% +31% +31% 34.14 TRANSPORT.UNSPECIFIED CATIONS 73 +16% +11% -16% +27% 34.15 TRANSPORT.POTASSIUM 62 -27% +35% +26% +35% 34.16 TRANSPORT.ABC TRANSPORTERS AND MULTIDRUG RESISTANCE SYSTEMS 132 +11% +24% +23% +33% 34.18 TRANSPORT.UNSPECIFIED ANIONS 30 +40% +23% +33% -23% 34.19.1 TRANSPORT.MAJOR INTRINSIC PROTEINS.PIP 39 +41% +38% +26% +23% 34.19.2 TRANSPORT.MAJOR INTRINSIC PROTEINS.TIP 18 -50% -50% +67% -17% 34.21 TRANSPORT.CALCIUM 47 -26% -9% -49% -47% 34.22 TRANSPORT.CYCLIC NUCLEOTIDE OR CALCIUM REGULATED CHANNELS 27 +44% +44% -19% +37% 34.99 TRANSPORT.MISC 152 +33% +34% +19% +20% 35.1.1 NOT ASSIGNED.NO ONTOLOGY.ABC1 FAMILY PROTEIN 20 -60% -30% +35% +45% 35.1.2 NOT ASSIGNED.NO ONTOLOGY.AGENET DOMAIN-CONTAINING PROTEIN 17 -47% -53% -18% +35% 35.1.3 NOT ASSIGNED.NO ONTOLOGY.ARMADILLO/BETA-CATENIN REPEAT FAMILY PROTEIN 51 +41% +29% +35% +20% 35.1.5 NOT ASSIGNED.NO ONTOLOGY.PENTATRICOPEPTIDE (PPR) REPEAT-CONTAINING PROTEIN 487 -67% -55% -38% -46% 35.1.12 NOT ASSIGNED.NO ONTOLOGY.PUMILIO/PUF RNA-BINDING DOMAIN-CONTAINING PROTEIN 16 -6% -6% +63% -6% 35.1.19 NOT ASSIGNED.NO ONTOLOGY.C2 DOMAIN-CONTAINING PROTEIN 49 +20% +22% +10% -27% 35.1.20 NOT ASSIGNED.NO ONTOLOGY.FORMIN HOMOLOGY 2 DOMAIN-CONTAINING PROTEIN 19 -58% -26% -26% -26% 35.1.21 NOT ASSIGNED.NO ONTOLOGY.EPSIN N-TERMINAL HOMOLOGY (ENTH) DOMAIN-CONTAINING PROTEIN 19 +11% +53% -37% -26% 35.1.27 NOT ASSIGNED.NO ONTOLOGY.TETRATRICOPEPTIDE REPEAT (TPR) 38 -34% -24% -11% -39% 35.1.40 NOT ASSIGNED.NO ONTOLOGY.GLYCINE RICH PROTEINS 29 +55% +28% +52% +17% 35.1.41 NOT ASSIGNED.NO ONTOLOGY.HYDROXYPROLINE RICH PROTEINS 65 +22% +42% -28% -14%
Export PNG
Creators and Submitter
Activity
Views: 1329 Downloads: 133
Created: 11th Apr 2022 at 15:01
Last updated: 21st Sep 2022 at 10:46
AttributionsNone
Version History
Version 1 (earliest) Created 11th Apr 2022 at 15:01 by Marko Petek
No revision comments
Related items
Advanced People list for this Data file with search and filtering
https://orcid.org/0000-0003-3644-7827PhD in Biotechnology, Research Associate at Department of Biotechnology and Systems Biology, National Institute of Biology
Advanced Programmes list for this Data file with search and filtering
National Institute of Biology, Department of Biotechnology and Systems Biology projects
Projects: HYp - Spatiotemporal analysis of hypersensitive response to Potato virus Y in potato, pISA-tree, MOA - Multiomics analysis of potato response to Potato virus Y (PVY) infection, SUSPHIRE - Sustainable Bioproduction of Pheromones for Insect Pest Control in Agriculture, INDIE - Biotechnological production of sustainable indole, _p_stRT, ADAPT - Accelerated Development of multiple-stress tolerAnt PoTato, _p_RNAinVAL, tst, tst2, Playground
Web page: http://www.nib.si/eng/index.php/departments/department-of-biotechnology-and-systems-biology
Advanced Projects list for this Data file with search and filtering
SUSPHIRE aims to provide a sustainable, low-cost biomanufacturing platform for the commercial production of insect pheromones.
Synthetic biology data management spreadsheet: https://fairdomhub.org/data_files/6036
Programme: NIBSys
Public web page: http://susphire.info/susphireproject/
Start date: 1st Apr 2018
End date: 30th Sep 2021
Advanced Investigations list for this Data file with search and filtering
Short Name: T21_SXPsysbio Title: Use a systems biology approach to identify regulatory bottlenecks in SxPv1 Description: Samples from SXPv1.0 plants as well as sister nulls (progeny from the original transgenic event in which the transgene has segregated) and wild type will be grown and leaf samples taken for RNA extraction and profiling of primary metabolites and volatiles (target pheromones as well as potential derivatives) (P1, P5). Phenotypic and GC-MS data will be obtained and analysed from ...
Submitter: Marko Petek
Studies: Investigation files, _S_P1_SPv10T0andT1, _S_P1_SPv10T2andT3, _S_P1_SPv1TransientExp, _S_P1_SxPAltAcTransferases, _S_P1_SxPv10vsSxP12, _S_P1_SxPv12T2, _S_P4_CoExpNetViz, _S_P4_DiNAR, _S_P4_GAtreat, _S_P4_SxP10-newG-DE, _S_P4_SxP10-oldG-DE, _S_P4_SxP1012-finalG, _S_P4_SxP12-newG-DE
Assays: _A_00_SxP_photos-phenotyping, _A_01_RNA1-RNAisol, _A_01_SxP_Data_Only-CoExp, _A_01_SxPv12_fastq-QC, _A_01_mapping-CLC, _A_01_toNewGenome-CLC-mapping, _A_02_FastQC-bioinfo, _A_02_Nb_datasets-CoExp, _A_02_SxPv12_mapping-CLC, _A_02_limmavoomDE-R, _A_02a_limmavoom-multim-R, _A_02a_limmavoomDEbylines-R, _A_02b_limmavoom-uniquem-R, _A_03_MapMan-visualisation, _A_03_NewGenome-MapMan, _A_03_SxPv12_limmavoom_DE-R, _A_03_mapping-CLC, _A_03a_mapping2-STAR, _A_04_GSEA-Stat, _A_04_MapManBINenrich-GSEA, _A_04_Mercator-bioinfo, _A_04_SxPv12_GeneSetEnrichment-RNAseg-GSEA, _A_05_DEstat-R, _A_05_Phenotype_analysis-Stat, _A_05_VOCcomp-Bioinfo, _A_05a_DEstat2-R, _A_05b_DElow-wt-R, _A_06_MapMan-bioinfo, _A_06_SxPv1-0_Illumina-Centrifuge, _A_07_NbAUSv1-0-InterPro, _A_07_transgenes-CLC, _A_CKN-DiNAR, _A_CKN_NbL35-DiNAR, _A_LeavesSxPv10vsv12-GCMS, _A_P4_v10v12-phenotyping, _A_PIS-DiNAR, _A_PIS-SxPv12-DiNAR, _A_PIS_NbL35-DiNAR, _A_RootsSxPv10vsv12-GCMS, _A_SP10T0Analysis-GCMS, _A_SP10T1Analysis-GCMS, _A_SPv10EaDActAnalysis-GCMS, _A_SPv10T2Analysis-GCMS, _A_SPv10T3Analysis-GCMS, _A_SPv10_phenotyping-Images, _A_SxPAlternativeAcetyltransferases-GCMS, _A_SxPv10vsv12-phenotyping, _A_SxPv12ScreeningT2-GCMS, _A_TransientSPv11andSPv12-GCMS, _I_T21_SXPsysbio-files, _S_P1_SPv10T0andT1-files, _S_P1_SPv10T2andT3-files, _S_P1_SPv1TransientExp-files, _S_P1_SxPAltAcTransferases-files, _S_P1_SxPv10vsSxP12-files, _S_P1_SxPv12T2-files, _S_P4_CoExpNetViz-files, _S_P4_DiNAR-files, _S_P4_GAtreat-files, _S_P4_SxP10-newG-DE-files, _S_P4_SxP10-oldG-DE-files, _S_P4_SxP1012-finalG-files, _S_P4_SxP12-newG-DE-files
Advanced Studies list for this Data file with search and filtering
Short Name: P4_SxP1012-finalG Title: Reanalysis of SxP Illumina reads with Nb genome V3.5 Description: * Raw Data: Principal investigator: Ĺ pela Baebler License: Creative Commons Attribution 4.0 Sharing permission: Private Upload to FAIRDOMHub: Yes
Advanced Assays list for this Data file with search and filtering
Short Name: 04_MapManBINenrich-GSEA Assay Class: DRY Assay Type: GSEA Title: GSEA for SxP Illumina mapped reads Description: GSEA of TMM normalized total counts from mapping of SxP Illumina reads to Nb genome v3.5 pISA Assay creation date: 2021-12-31 pISA Assay creator: Mojca Jutersek Phenodata: None Featuredata: Data:
Submitter: Marko Petek
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: _I_T21_SXPsysbio
Study: _S_P4_SxP1012-finalG
